"Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2012" Published
Global Markets Direct's, 'Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2012', provides an overview of the Neuro Endocrine (Carcinoid) Carcinoma therapeutic pipeline. This report provides information on the therapeutic development for Neuro Endocrine (Carcinoid) Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuro Endocrine (Carcinoid) Carcinoma. 'Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2012' is built using data and information sourced from...
View full press release